BRIEF published on 06/14/2024 at 22:50, 2 years ago Reminder Notice of Annual General and Special Meeting for Shareholders of Theralase® Shareholders Theralase® Virtual Meeting AGSM Zoom Presentation
BRIEF published on 06/14/2024 at 22:50, 2 years ago Avis de rappel d'assemblée générale annuelle et extraordinaire des actionnaires de Theralase® Actionnaires Theralase® Réunion Virtuelle AGSM Présentation Zoom
PRESS RELEASE published on 06/14/2024 at 22:45, 2 years ago Reminder Notice of Annual General and Special Meeting for Shareholders of Theralase(R) Theralase Technologies Inc. provides a reminder for its Annual General and Special Meeting to be held on June 19th, 2024, with a virtual Zoom presentation including a Q&A session for shareholders Annual General Meeting Shareholders Theralase Technologies Inc. AGSM Virtual Zoom Presentation
BRIEF published on 06/12/2024 at 13:05, 2 years ago Rutherrin® Increases Efficacy of Chemotherapy Cancer Treatment Chemotherapy Rutherrin® Multidrug Resistance Theralase® Technologies
BRIEF published on 06/12/2024 at 13:05, 2 years ago Rutherrin® augmente l'efficacité de la chimiothérapie Traitement Du Cancer Chimiothérapie Rutherrin® Résistance Multidrogue Technologies Theralase®
PRESS RELEASE published on 06/12/2024 at 13:00, 2 years ago Rutherrin(R) Increases Efficacy of Chemotherapy Theralase Technologies announces preclinical success of Rutherrin® in enhancing chemotherapy efficacy and reducing multidrug resistance in cancer cells Cancer Treatment Theralase Technologies Rutherrin® Multidrug Resistance Chemotherapy Efficacy
BRIEF published on 06/10/2024 at 13:05, 2 years ago Ruvidar(TM) Enhances Efficacy of Cancer Drug Cancer Treatment Theralase Technologies Ruvidar(TM) BCG NMIBC
BRIEF published on 06/10/2024 at 13:05, 2 years ago Ruvidar(TM) améliore l'efficacité d'un médicament contre le cancer Traitement Du Cancer Technologies Théralase Ruvidar(TM) BCG NMIBC
PRESS RELEASE published on 06/10/2024 at 13:00, 2 years ago Ruvidar(TM) Enhances Efficacy of Cancer Drug Theralase® Technologies Inc. announces breakthrough in cancer research by developing RuBCG compound to enhance efficacy of bladder cancer treatment. Preclinical results show promising potential Theralase Technologies Inc. Cancer Research RuBCG Compound Bladder Cancer Treatment Preclinical Results
BRIEF published on 06/06/2024 at 13:05, 2 years ago Theralase Successfully Destroys Lung Cancer Preclinical Study Theralase Technologies Lung Cancer Rutherrin®
Published on 06/30/2026 at 02:00, 5 hours 30 minutes ago MedMira Reports Third Quarter Results FY2026
Published on 06/30/2026 at 00:05, 7 hours 25 minutes ago American Critical Minerals Announces Completion of Warrant Exercise Incentive Program
Published on 06/29/2026 at 23:46, 7 hours 44 minutes ago 1933 Industries Reports Third Quarter 2026 Financial Results
Published on 06/29/2026 at 22:01, 9 hours 29 minutes ago AIP Realty Trust Announces Voting Results of Annual General and Special Meeting of Unitholders
Published on 06/30/2026 at 07:13, 16 minutes ago L’AGF nomme M. Constant N’ZI au poste de Directeur Général du Groupe
Published on 06/30/2026 at 07:13, 16 minutes ago African Guarantee Fund appoints Mr. Constant N’ZI as Group Chief Executive Officer
Published on 06/30/2026 at 07:05, 25 minutes ago Infracore SA communique la décision de la Commission des offres publiques d'acquisition
Published on 06/30/2026 at 07:05, 25 minutes ago Infracore SA communicates the decision of the Swiss Takeover Board
Published on 06/30/2026 at 07:00, 30 minutes ago Kontron AIS Wins Major Software Contract for Rail Yard Modernization in Belgium
Published on 06/30/2026 at 07:00, 30 minutes ago bioMérieux submits 510(k) to U.S. FDA for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens
Published on 06/30/2026 at 07:00, 30 minutes ago bioMérieux dépose une demande d’autorisation à la FDA américaine pour les nouvelles versions de ses tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’améliorer la détection des agents pathogènes gastrointestinaux
Published on 06/29/2026 at 18:30, 13 hours ago Accor and H World Group expand long-term partnership across direct booking and loyalty platforms
Published on 06/29/2026 at 18:30, 13 hours ago Accor et H World Group : extension du partenariat de long terme aux plateformes de réservation directe et de fidélité
